CL2025001819A1 - Compuestos derivados de tiadiazol y uso como inhibidores de cgamp sintasa (cgas). - Google Patents
Compuestos derivados de tiadiazol y uso como inhibidores de cgamp sintasa (cgas).Info
- Publication number
- CL2025001819A1 CL2025001819A1 CL2025001819A CL2025001819A CL2025001819A1 CL 2025001819 A1 CL2025001819 A1 CL 2025001819A1 CL 2025001819 A CL2025001819 A CL 2025001819A CL 2025001819 A CL2025001819 A CL 2025001819A CL 2025001819 A1 CL2025001819 A1 CL 2025001819A1
- Authority
- CL
- Chile
- Prior art keywords
- cgas
- inhibitors
- thiadiazole derivatives
- cgamp synthase
- cgamp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263433987P | 2022-12-20 | 2022-12-20 | |
| US202363501320P | 2023-05-10 | 2023-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2025001819A1 true CL2025001819A1 (es) | 2025-09-26 |
Family
ID=89768384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2025001819A CL2025001819A1 (es) | 2022-12-20 | 2025-06-18 | Compuestos derivados de tiadiazol y uso como inhibidores de cgamp sintasa (cgas). |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240270740A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4638446A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7870987B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250131845A (cg-RX-API-DMAC7.html) |
| CN (1) | CN120530109A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023408761A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2025001819A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2025007987A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL321525A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025007158A (cg-RX-API-DMAC7.html) |
| PE (1) | PE20251918A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202434205A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024137607A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026077404A1 (zh) * | 2024-10-10 | 2026-04-16 | 北京知维拓医药科技有限公司 | 一种杂环类化合物及其用途 |
| WO2026158338A1 (zh) * | 2025-01-22 | 2026-07-30 | 北京知维拓医药科技有限公司 | 一种杂环类化合物及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| JP2016506408A (ja) | 2012-12-19 | 2016-03-03 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 哺乳動物の環状ジヌクレオチドシグナル伝達経路の薬学的標的化 |
| DK3439667T3 (da) * | 2016-04-05 | 2024-04-02 | Immune Sensor Llc | Cgas antagonist forbindelser |
| US10738056B2 (en) * | 2017-09-15 | 2020-08-11 | Aduro Biotech Inc. | Pyrazolopyrimidinone compounds and uses thereof |
| MX2020008237A (es) | 2018-02-05 | 2020-09-25 | Univ Rockefeller | Inhibidores de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol de cgas para tratar enfermedades autoinflamatorias. |
| WO2020072492A1 (en) * | 2018-10-02 | 2020-04-09 | Baruch S. Blumberg Institute | Benzamide derivatives as cgas-sting pathway agonists |
| JP7781074B2 (ja) * | 2020-05-20 | 2025-12-05 | エフ. ホフマン-ラ ロシュ アーゲー | Cgas阻害トリアゾロピリミドン誘導体 |
| WO2022137082A1 (en) * | 2020-12-22 | 2022-06-30 | Novartis Ag | Pyrrolo[3,2-b]pyridine derivatives useful in treating conditions associated with cgas |
| KR20230124665A (ko) * | 2020-12-22 | 2023-08-25 | 노파르티스 아게 | Cgas 관련 병태의 치료에 유용한 인돌 유도체 |
| EP4778593A2 (en) * | 2021-11-08 | 2026-07-22 | Ventus Therapeutics U.S., Inc. | Heterocyclic compounds and uses thereof |
| CN115160279B (zh) * | 2022-07-27 | 2023-11-24 | 中国药科大学 | 苯并吡喃酮类化合物、药物组合物和应用 |
-
2023
- 2023-12-19 EP EP23848029.7A patent/EP4638446A1/en active Pending
- 2023-12-19 KR KR1020257024220A patent/KR20250131845A/ko active Pending
- 2023-12-19 TW TW112149428A patent/TW202434205A/zh unknown
- 2023-12-19 PE PE2025001310A patent/PE20251918A1/es unknown
- 2023-12-19 AU AU2023408761A patent/AU2023408761A1/en active Pending
- 2023-12-19 WO PCT/US2023/084787 patent/WO2024137607A1/en not_active Ceased
- 2023-12-19 CN CN202380091713.0A patent/CN120530109A/zh active Pending
- 2023-12-19 US US18/544,945 patent/US20240270740A1/en active Pending
- 2023-12-19 IL IL321525A patent/IL321525A/en unknown
- 2023-12-19 JP JP2025536183A patent/JP7870987B2/ja active Active
-
2025
- 2025-06-13 CO CONC2025/0007987A patent/CO2025007987A2/es unknown
- 2025-06-18 MX MX2025007158A patent/MX2025007158A/es unknown
- 2025-06-18 CL CL2025001819A patent/CL2025001819A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7870987B2 (ja) | 2026-06-08 |
| AU2023408761A1 (en) | 2025-06-19 |
| IL321525A (en) | 2025-08-01 |
| PE20251918A1 (es) | 2025-08-05 |
| US20240270740A1 (en) | 2024-08-15 |
| CO2025007987A2 (es) | 2025-09-08 |
| TW202434205A (zh) | 2024-09-01 |
| EP4638446A1 (en) | 2025-10-29 |
| KR20250131845A (ko) | 2025-09-03 |
| MX2025007158A (es) | 2025-07-01 |
| CN120530109A (zh) | 2025-08-22 |
| WO2024137607A1 (en) | 2024-06-27 |
| JP2026501225A (ja) | 2026-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022001357A2 (es) | Inhibidores de shp2 fosfatasa de tipo pirazolo[3,4-b]pirazina | |
| PE20240881A1 (es) | Uso de un inhibidor de la ezh2 en la preparacion de farmacos para el tratamiento del linfoma de linfocitos t | |
| CO6470846A2 (es) | Derivados aminobut´ricos sustituidos como inhibidores de neprilisina | |
| CO2025007987A2 (es) | Derivados de tiadiazol como inhibidores de la sintasa de gmp-amp cíclico y usos de los mismos | |
| CU20110217A7 (es) | Derivados amino-propiónicos sustituidos como inhibidores de neprilisina | |
| AR066214A1 (es) | Derivados de pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas. usos y composiciones farmaceuticas | |
| ECSP088404A (es) | Nuevos derivados de imidazo[4,5-b]piridina como inhibidores de la glucógeno sintasa quinasa 3, para uso en el tratamiento de demencia y trastornos neurodegenerativos | |
| CO2023000056A2 (es) | Derivados de amidopirimidona | |
| AR039385A1 (es) | Derivados de tioxantina como inhibidores de la mieloperoxidasa | |
| CL2024002855A1 (es) | Derivados de pirido-[3,4-d]piridazina amina útiles como derivados de nlrp3. | |
| CR11208A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas | |
| CL2022002975A1 (es) | Compuestos y composiciones para inhibir la actividad de hif2-alfa y sus métodos de uso | |
| AR039190A1 (es) | Derivados de benzofurano, composicion farmaceutica y medicamento que comprende el compuesto | |
| CL2023000387A1 (es) | Derivados de dioxoloisoquinolinona novedosos y uso de los mismos | |
| CL2025000672A1 (es) | Compuestos derivados de aminopirimidina, inhibidores de cdk2; composición farmacéutica; uso para tratar cáncer. | |
| CO2024015371A2 (es) | Derivados de oxoindolinil amida para inhibir nlrp3 y usos de los mismos | |
| CL2023000418A1 (es) | Derivados de espiropiperidinilo sustituidos con heteroarilo y usos farmacéuticos de los mismos | |
| CO2025014389A2 (es) | Derivados de amida para inhibir nlrp3 y usos de estos | |
| DOP2022000073A (es) | Derivados de 2-azaspiro[3,4]octano como agonistas de m4 | |
| CL2021003139A1 (es) | Compuestos tricíclicos | |
| BR112022007543A2 (pt) | Derivados de tiofeno como inibidores de xantina oxidase e aplicação dos mesmos | |
| EA202192111A1 (ru) | Новые тритерпеновые производные в качестве ингибиторов вич | |
| ECSP23075535A (es) | Compuestos cíclicos y métodos de uso | |
| MX2022015532A (es) | Inhibidores selectivos de hdac6 y usos de los mismos. | |
| AR131443A1 (es) | Inhibidores de gmp-amp sintasa cíclica y sus usos |